Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Jun;35(6):795–808. doi: 10.1038/bjc.1977.121

Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.

P W Sheldon, S A Hill
PMCID: PMC2025527  PMID: 871367

Abstract

Tumour experiments including local control after X-irradiation have been performed, using a new technique that eliminates the need for anaesthetics in restraining the animals. This system has been used to investigate the degree of sensitization that can be achieved with ICRF 159 and 4 strongly electron-affinic radiosensitizers, nifurpipone dihydrochloride, metronidazole, Ro-11-3696 and Ro-07-0582. No significant enhancement of the radiation effect was observed with ICRF 159. Significant sensitization was achieved by all 4 nitro-heterocyclic compoinds, Ro-07-0582 being the most effective, metronidazole and Ro-11-3696 the next, and nifurpipone dihydrochloride the least effective. For Ro-07-0582 and metronidazole, several concentrations were investigated, and the interval between injection with Ro-07-0582 and irradiation was varied: an interval of 30 min gave more sensitization than an interval of 90 min. The results from the local control experiments using Ro-07-0582 have been compared with those obtained from regrowth delay experiments. The radiosensitization obtained by the Ro-07-0582 increased with the X-ray dose above 25 gray. Both metronidazole and Ro-07-0582 gave significant enhancement effect at serum concentrations which can be achieved in man.

Full text

PDF
795

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. E. Chemical radiosensitization of hypoxic cells. Br Med Bull. 1973 Jan;29(1):48–53. doi: 10.1093/oxfordjournals.bmb.a070956. [DOI] [PubMed] [Google Scholar]
  2. Adams G. E., Flockhart I. R., Smithen C. E., Stratford I. J., Wardman P., Watts M. E. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res. 1976 Jul;67(1):9–20. [PubMed] [Google Scholar]
  3. Asquith J. C., Foster J. L., Willson R. L., Ings R., McFadzean J. A. Metronidazole ("Flagyl"). A radiosensitizer of hypoxic cells. Br J Radiol. 1974 Aug;47(560):474–481. doi: 10.1259/0007-1285-47-560-474. [DOI] [PubMed] [Google Scholar]
  4. Asquith J. C., Watts M. E., Patel K., Smithen C. E., Adams G. E. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res. 1974 Oct;60(1):108–118. [PubMed] [Google Scholar]
  5. Begg A. C., Sheldon P. W., Foster J. L. Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. Br J Radiol. 1974 Jul;47(559):399–404. doi: 10.1259/0007-1285-47-559-399. [DOI] [PubMed] [Google Scholar]
  6. Brown J. M. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582. Radiat Res. 1975 Dec;64(3):633–647. [PubMed] [Google Scholar]
  7. Chapman J. D., Reuvers A. P., Borsa J. Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to x rays. Br J Radiol. 1973 Aug;46(548):623–630. doi: 10.1259/0007-1285-46-548-623. [DOI] [PubMed] [Google Scholar]
  8. DE OLIVARIUS B. F. Polyneuropathi ved behandling med nitrofurantoin. Ugeskr Laeger. 1956 Jun 28;118(26):753–755. [PubMed] [Google Scholar]
  9. Denekamp J., Harris S. R. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma. Radiat Res. 1975 Feb;61(2):191–203. [PubMed] [Google Scholar]
  10. Denekamp J., Michael B. D., Harris S. R. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiat Res. 1974 Oct;60(1):119–132. [PubMed] [Google Scholar]
  11. Deutsch G., Foster J. L., McFadzean J. A., Parnell M. Human studies with "high dose" metronidazole: a non-toxic radiosensitizer of hypoxic cells. Br J Cancer. 1975 Jan;31(1):75–80. doi: 10.1038/bjc.1975.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Foster J. L., Flockhart I. R., Dische S., Gray A., Lenox-Smith I., Smithen C. E. Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results. Br J Cancer. 1975 Jun;31(6):679–683. doi: 10.1038/bjc.1975.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Foster J. L., Willson R. L. Radiosensitization of anoxic cells by metronidazole. Br J Radiol. 1973 Mar;46(543):234–235. doi: 10.1259/0007-1285-46-543-234. [DOI] [PubMed] [Google Scholar]
  15. Fowler J. F. Current aspects of radiobiology as applied to radiotherapy. Clin Radiol. 1972 Jul;23(3):257–262. doi: 10.1016/s0009-9260(72)80042-4. [DOI] [PubMed] [Google Scholar]
  16. Fowler J. F., Sheldon P. W., Begg A. C., Hill S. A., Smith A. M. Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice. Int J Radiat Biol Relat Stud Phys Chem Med. 1975 May;27(5):463–480. doi: 10.1080/09553007514550461. [DOI] [PubMed] [Google Scholar]
  17. Gray A. J., Dische S., Adams G. E., Flockhart I. R., Foster J. L. Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol. 1976 Apr;27(2):151–157. doi: 10.1016/s0009-9260(76)80137-7. [DOI] [PubMed] [Google Scholar]
  18. Hellmann K., Burrage K. Control of malignant metastases by ICRF l59. Nature. 1969 Oct 18;224(5216):273–275. doi: 10.1038/224273a0. [DOI] [PubMed] [Google Scholar]
  19. Hellmann K., Murkin G. E. Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors. Cancer. 1974 Oct;34(4):1033–1039. doi: 10.1002/1097-0142(197410)34:4<1033::aid-cncr2820340412>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  20. Hewitt H. B., Chan D. P., Blake E. R. Survival curves for clonogenic cells of a murine keratinizing squamous carcinoma irradiated in vivo or under hypoxic conditions. Int J Radiat Biol Relat Stud Phys Chem Med. 1967;12(6):535–549. doi: 10.1080/09553006714551151. [DOI] [PubMed] [Google Scholar]
  21. Hill S. A., Fowler J. F. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour. Br J Cancer. 1977 Apr;35(4):461–469. doi: 10.1038/bjc.1977.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McNally N. J. The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro. Br J Cancer. 1975 Nov;32(5):610–618. doi: 10.1038/bjc.1975.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Peters L. J. A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour. Br J Cancer. 1975 Sep;32(3):355–365. doi: 10.1038/bjc.1975.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peters L. J. Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159. Br J Radiol. 1976 Aug;49(584):708–715. doi: 10.1259/0007-1285-49-584-708. [DOI] [PubMed] [Google Scholar]
  25. Rauth A. M., Kaufman K. In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique. Br J Radiol. 1975 Mar;48(567):209–220. doi: 10.1259/0007-1285-48-567-209. [DOI] [PubMed] [Google Scholar]
  26. Salsbury A. J., Burrage K., Hellmann K. Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic. Br Med J. 1970 Nov 7;4(5731):344–346. doi: 10.1136/bmj.4.5731.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schärer K. Selektive Purkinje-Zellschädingungen nach oraler Verabreichung gosser Dosen von Nitroimidazol-Derivaten am Hund. Verh Dtsch Ges Pathol. 1972;56:407–410. [PubMed] [Google Scholar]
  28. Sheldon P. W., Foster J. L., Fowler J. F. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer. 1974 Dec;30(6):560–565. doi: 10.1038/bjc.1974.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stone H. B., Withers H. R. Letter: Enhancement of the radioresponse of a murine tumour by a nitroimidazone. Br J Radiol. 1975 May;48(569):411–412. doi: 10.1259/0007-1285-48-569-411. [DOI] [PubMed] [Google Scholar]
  30. Stone H. B., Withers H. R. Tumor and normal tissue response to metronidazole and irradiation in mice. Radiology. 1974 Nov;113(2):441–444. doi: 10.1148/113.2.441. [DOI] [PubMed] [Google Scholar]
  31. THOMLINSON R. H. An experimental method for comparing treatments of intact malignant tumours in animals and its application to the use of oxygen in radiotherapy. Br J Cancer. 1960 Sep;14:555–576. doi: 10.1038/bjc.1960.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. THOMLINSON R. H., GRAY L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955 Dec;9(4):539–549. doi: 10.1038/bjc.1955.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thomlinson R. H., Dische S., Gray A. J., Errington L. M. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976 Apr;27(2):167–174. doi: 10.1016/s0009-9260(76)80139-0. [DOI] [PubMed] [Google Scholar]
  34. Urtasun R., Band P., Chapman J. D., Feldstein M. L., Mielke B., Fryer C. Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med. 1976 Jun 17;294(25):1364–1367. doi: 10.1056/NEJM197606172942503. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES